Abstract
Background -Although the causes of the worldwide resurgence of tuberculosis are multifactorial, the HIV epidemic is believed to have had a central role. Control is further threatened by the emergence of multidrug-resistant tuberculosis. Methods -A retrospective evaluation was undertaken of trends in pulmonary and extrapulmonary culture positive mycobacterial pathology, and the prevalence of drug-resistant tuberculosis in both HIV seropositive and, presumptively, HIV seronegative patients receiving their clinical care at St Mary's Hospital, London. Five hundred and thirty eight patients (188 of whom were known to be HIV seropositive) with positive mycobacterial isolates between January 1987 and March 1993 were identified from laboratory records. These were cross referenced with drug surveillance records. Results -Overall, between 1987 and 1992 there was a progressive 3'5 fold increase in positive mycobacterial isolates and a 2*5 fold increase in patients with proven mycobacterial infection. This increase was greater within the HIV seropositive population. A total of 663 positive mycobacterial isolates was evaluated; the major pathogen identified was Mycobacterium tuberculosis (379 isolates, 57%). Three hundred and fourteen patients were diagnosed as having M tuberculosis, 49 This increase was greater in the HIV seropositive population. Even so, our data may well represent an underestimation of diagnostic rates since patients in both subpopulations diagnosed on the basis of histopathology alone were not included. Our data may relate not only to an increase in the incidence of mycobacterial disease with time, but also to an increase in the number of patients within at risk groups in the local population. Secondly, as anticipated, the major mycobacterial pathogen in presumptive HIV seronegative patients was M tuberculosis which was principally pulmonary in origin. Thirdly, in contrast to urban areas of the USA where drug resistance is reported to be as high as 33%,6 our data do not show an emergence of drug-resistant tuberculosis in inner London with an incidence of only 4 5%. In the patients in our study in whom drug resistance was demonstrated, immigration, drug abuse, and previous antituberculous therapy may have been contributory. Only two of these patients were known to be HIV seropositive.
In the USA it has been estimated that up to 12% of patients with tuberculosis are seropositive for HIV infection.8 In our study, despite being conducted in a population with a high component of individuals infected with HIV, we found that 16% (49 of 314) of all patients with tuberculosis were known to be HIV seropositive. Whilst the HIV status of all presumptively seronegative patients with tuberculous disease in this study was not determined, our data endorse the fact that most patients with tuberculosis are unlikely to have HIV infection. Examining the relationship from the opposite perspective, the proportion of AIDS patients who develop tuberculosis has been variously estimated at 4-6%9 and 6.0%.lo We have estimated that the prevalence of mycobacterial disease for all patients newly registered with HIV infection was 9-6%. If only local notification records had been assessed, the incidence amongst HIV patients would have been 028% and this highlights an under reporting of tuberculosis infection in this group.
The role of M avium complex infection in patients with HIV disease and, particularly, its impact on survival in these patients is controversial."1-4 In those individuals presumptively HIV negative, infection with M avium alone occurred in 12-5% of patients (44 of 350) and in 91 of the 188 HIV seropositive patients (48%). These figures are surprisingly high. However, falsely negative HIV status, clinical relevance of certain cultures (for example, stool cultures), high incidence of alcoholism and malnutrition in the population studied, ethnicity, inclusion of M scrofulaceum in the "MAIS" complex in the laboratory, and the diagnostic difficulties encountered with the biochemical identification methods used in the laboratory during the study period (compared with the currently used gene probe techniques) partly explain this finding. The HIV seropositive group was almost invariably culture positive during the later stages of AIDS and, given our finding of a four month mean survival following culture diagnosis of M avium (data not shown), the likelihood is that many of these individuals were at the later stages ofthe disease process.
Equally, the significant incidence of extrapulmonary tuberculous infection in 25% of the HIV seronegative group is important. The explanation for this is not clear, and its relevance depends on the clinical setting. Falsely negative HIV seronegative status is a clinically important explanation. Notwithstanding this, these positive isolates might also be attributable to reactivation of old disease in ethnic groups and dissemination of infection in immunocompromised individuals who do not have HIV infection, both of which are relevant to this population.
In summary, this retrospective study highlights the trends in mycobacterial infection over a six year period at an inner London teaching hospital. The incidence of tuberculosis seems to be increasing in HIV seropositive and seronegative populations at a rate similar to that at other centres. Drug resistance does not appear to occur on the scale reported in the USA. The influence of HIV infection is complex. Prospective studies looking at known seropositive individuals and routine testing of presumptively seronegative patients with mycobacterial infection will allow further accurate evaluation of the impact of HIV. 
